Herzog & de Meuron's AstraZeneca HQ hit by further delays

Herzog & de Meuron's AstraZeneca headquarters in Cambridge

Completion put back to 2020 as cost spirals

 Further delays to the construction of pharmaceutical giant AstraZeneca’s new headquarters in Cambridge could push the building’s final price tag to more than £500m.

Completion of the Herzog & de Meuron-designed project is now expected in the first half of 2020, nearly three years behind schedule.

AstraZeneca, which develops treatments for heart disease, cancer and respiratory illnesses, had expected to move into the building, located on the Cambridge Biomedical Campus, in the latter part of last year.

 …

This content is available to registered users | Already registered?Login here

You are not currently logged in.

To continue reading this story, sign up for free guest access

Existing Subscriber? LOGIN

REGISTER for free access on selected stories and sign up for email alerts. You get:

  • Up to the minute architecture news from around the UK
  • Breaking, daily and weekly e-newsletters

 

Subscribe to Building Design and you will benefit from:

Gated access promo

  • Unlimited news
  • Reviews of the latest buildings from all corners of the world
  • Technical studies
  • Full access to all our online archives
  • PLUS you will receive a digital copy of WA100 worth over £45

Subscribe now for unlimited access.